Seeking Alpha

A pump from Johnson & Johnson (JNJ) automatically calculated and delivered the right amount...

A pump from Johnson & Johnson (JNJ) automatically calculated and delivered the right amount of insulin to patients with Type 1 diabetes at night in a study involving 20 adults. The diabetics' blood-sugar levels were in the recommended range for over 90% of the night. The subjects were under supervision on an overnight visit to testing facilities during the study; J&J plans to conduct another of these feasibility trials before starting evaluations in which the patients use the device at home. (See Medtronics pump)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|